Analyst Price Target is C$0.98
▲ +716.67% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Delta 9 Cannabis in the last 3 months. The average price target is C$0.98, with a high forecast of C$0.98 and a low forecast of C$0.98. The average price target represents a 716.67% upside from the last price of C$0.12.
Current Consensus is
The current consensus among 1 polled investment analysts is to buy stock in Delta 9 Cannabis. This Buy consensus rating has held steady for over two years.
Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, decontamination pods, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. As of April 20, 2022, the company owned and operated 35 retail stores under the Delta 9 brand name across the Canadian Prairies. Delta 9 Cannabis Inc. was incorporated in 2001 and is headquartered in Winnipeg, Canada.